Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

241 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study.
Joly P, Roujeau JC, Benichou J, Delaporte E, D'Incan M, Dreno B, Bedane C, Sparsa A, Gorin I, Picard C, Tancrede-Bohin E, Sassolas B, Lok C, Guillaume JC, Doutre MS, Richard MA, Caux F, Prost C, Plantin P, Chosidow O, Pauwels C, Maillard H, Saiag P, Descamps V, Chevrant-Breton J, Dereure O, Hellot MF, Esteve E, Bernard P. Joly P, et al. Among authors: bedane c. J Invest Dermatol. 2009 Jul;129(7):1681-7. doi: 10.1038/jid.2008.412. Epub 2009 Jan 29. J Invest Dermatol. 2009. PMID: 19177141 Free article. Clinical Trial.
[One year follow-up of patients with bullous pemphigoid].
Doffoel-Hantz V, Sparsa A, Marin B, Durox H, Bonnetblanc JM, Bédane C. Doffoel-Hantz V, et al. Among authors: bedane c. Ann Dermatol Venereol. 2009 May;136(5):407-11. doi: 10.1016/j.annder.2009.01.009. Epub 2009 Apr 23. Ann Dermatol Venereol. 2009. PMID: 19442795 French.
Risk factors for bullous pemphigoid in the elderly: a prospective case-control study.
Bastuji-Garin S, Joly P, Lemordant P, Sparsa A, Bedane C, Delaporte E, Roujeau JC, Bernard P, Guillaume JC, Ingen-Housz-Oro S, Maillard H, Pauwels C, Picard-Dahan C, Dutronc Y, Richard MA; French Study Group for Bullous Diseases. Bastuji-Garin S, et al. Among authors: bedane c. J Invest Dermatol. 2011 Mar;131(3):637-43. doi: 10.1038/jid.2010.301. Epub 2010 Oct 14. J Invest Dermatol. 2011. PMID: 20944650 Free article.
Incidence and mortality of bullous pemphigoid in France.
Joly P, Baricault S, Sparsa A, Bernard P, Bédane C, Duvert-Lehembre S, Courville P, Bravard P, Rémond B, Doffoel-Hantz V, Bénichou J. Joly P, et al. Among authors: bedane c. J Invest Dermatol. 2012 Aug;132(8):1998-2004. doi: 10.1038/jid.2012.35. Epub 2012 Mar 15. J Invest Dermatol. 2012. PMID: 22418872 Free article.
Visible light-induced solar urticaria is improved by omalizumab.
Moncourier M, Assikar S, Matei I, Souyri N, Couture M, Rigot E, Delauménie S, Bédane C. Moncourier M, et al. Among authors: bedane c. Photodermatol Photoimmunol Photomed. 2016 Sep;32(5-6):314-316. doi: 10.1111/phpp.12271. Epub 2016 Sep 29. Photodermatol Photoimmunol Photomed. 2016. PMID: 27622987 No abstract available.
241 results